Arnuity Ellipta can cost up to $299 without insurance. Here's how to save with coupons, discount cards, and patient assistance programs in 2026.
If you've ever picked up your Arnuity Ellipta prescription without insurance and seen a price tag of nearly $300, you know this medication isn't cheap. For a medication you need every single day to manage your asthma, that kind of cost adds up fast — potentially over $3,500 a year.
The good news is that there are real ways to bring that cost down significantly. In this guide, we'll break down exactly what Arnuity Ellipta costs in 2026, and walk you through every savings option available — from manufacturer coupons to patient assistance programs to discount cards.
Here are the current cash prices for Arnuity Ellipta in 2026:
The price can vary depending on the strength (50 mcg, 100 mcg, or 200 mcg), your pharmacy, and your location. Without any insurance or discounts, you're looking at roughly $3,156 to $3,588 per year for this one medication.
That's a lot of money. Let's look at how to bring it down.
GlaxoSmithKline (GSK), the maker of Arnuity Ellipta, offers a copay savings program through their GSK For You platform. Here's what you need to know:
This is typically the best deal available for commercially insured patients. If you have private insurance and you're paying a high copay for Arnuity Ellipta, this should be your first stop.
If you don't have insurance or the GSK savings program doesn't apply to you, discount cards can provide meaningful savings:
Several other discount card providers may offer savings on Arnuity Ellipta. It's worth comparing prices across multiple platforms since prices can vary by pharmacy:
Important: Discount cards cannot be combined with insurance. You use them instead of insurance when the cash price with a coupon is lower than your insured copay. Ask your pharmacist to compare both prices before you pay.
If you're uninsured or underinsured and have limited income, you may qualify for free Arnuity Ellipta through a patient assistance program:
Prasco Laboratories launched an authorized generic version of Arnuity Ellipta (Fluticasone Furoate inhalation powder) in July 2025. It's the same medication in the same Ellipta device. As pharmacy adoption increases, the generic may be available at a lower price than the brand. Ask your pharmacist if they carry it.
Many insurance plans offer lower copays for 90-day mail-order prescriptions compared to 30-day retail fills. If you're on a stable dose of Arnuity Ellipta, switching to mail order could save you money each quarter. Contact your insurance plan to check mail-order options and pricing.
Prices for the same medication can vary by $50 or more between pharmacies in the same area. Use Medfinder to check availability and tools like GoodRx to compare prices. Don't assume your usual pharmacy has the best deal.
If cost is a primary concern, talk to your doctor about switching to a less expensive inhaled corticosteroid. Generic Budesonide (Pulmicort Flexhaler) and generic Fluticasone Propionate (Flovent) are typically more affordable than Arnuity Ellipta. For more details, read our guide on alternatives to Arnuity Ellipta.
Some states offer pharmaceutical assistance programs for residents who can't afford their medications. These programs vary by state and may cover inhaled corticosteroids like Arnuity Ellipta. Contact your state's department of health or visit needymeds.org to search for programs in your area.
Nobody should have to skip their asthma medication because of cost. Between the GSK savings program, discount cards like GoodRx, patient assistance foundations, and the new authorized generic, there are meaningful ways to reduce what you pay for Arnuity Ellipta in 2026.
Start with the option that fits your situation:
For help finding Arnuity Ellipta in stock near you, visit Medfinder. For more information about this medication, check out our guides on what Arnuity Ellipta is and Arnuity Ellipta side effects.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
